Pathogenic microorganism DNA high-throughput genetic sequencing to diagnose peritoneal dialysis-associated

Rui-Feng Xu1, Wu-Niri Gao1, Ta-la Hu1

  • 1Department of Nephrology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010050, Inner Mongolia, PR China.

BMC Nephrology
|September 3, 2024
PubMed

Insights

Peritonitis from Mycobacterium tuberculosis is rare in peritoneal dialysis patients. Pathogen DNA sequencing aids early diagnosis and treatment for better patient outcomes.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Genomics

Background:

  • Peritoneal dialysis-associated peritonitis is a significant complication impacting patient survival and quality of life.
  • Diagnosing tuberculosis (Mycobacterium tuberculosis) peritonitis in peritoneal dialysis patients is challenging due to its rarity.

Observation:

  • A rare case of peritoneal dialysis-associated peritonitis caused by Mycobacterium tuberculosis infection is presented.
  • The causative agent was identified using pathogenic microbial DNA high-throughput genetic sequencing.

Findings:

  • High-throughput genetic sequencing of pathogenic microbial DNA offers a powerful tool for identifying microorganisms.
  • This advanced sequencing method can improve detection rates in complex patient cases.

Implications:

  • Early and accurate diagnosis of rare pathogens like Mycobacterium tuberculosis is crucial for timely treatment.
  • Pathogen DNA sequencing can enhance the management of peritoneal dialysis-associated peritonitis, especially in complicated scenarios.
  • This approach holds promise for improving patient outcomes in peritoneal dialysis by enabling faster initiation of appropriate therapies.